cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide

C22H18N6O2 — CID 135342332

IUPACcis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide
SMILESCn1c(=O)n(-c2cc(N)c3cnc(NC(=O)[C@@H]4C[C@H]4C#N)cc3c2)c2ccccc21
InChIInChI=1S/C22H18N6O2/c1-27-18-4-2-3-5-19(18)28(22(27)30)14-6-12-8-20(25-11-16(12)17(24)9-14)26-21(29)15-7-13(15)10-23/h2-6,8-9,11,13,15H,7,24H2,1H3,(H,25,26,29)/t13-,15+/m0/s1
InChIKeyYFZHOGUJFUDAPU-DZGCQCFKSA-N
MW398.43 g/mol
LogP2.56
Rot. Bonds3

About cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide

cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide (PubChem CID 135342332) has the molecular formula C22H18N6O2 and a molecular weight of 398.43 g/mol. Its IUPAC name is cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide.

Molecular Properties

Compound Namecis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide
PubChem CID135342332
Molecular FormulaC22H18N6O2
Molecular Weight398.43 g/mol
Exact Mass398.15
IUPAC Namecis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide
SMILESCn1c(=O)n(-c2cc(N)c3cnc(NC(=O)[C@@H]4C[C@H]4C#N)cc3c2)c2ccccc21
InChIInChI=1S/C22H18N6O2/c1-27-18-4-2-3-5-19(18)28(22(27)30)14-6-12-8-20(25-11-16(12)17(24)9-14)26-21(29)15-7-13(15)10-23/h2-6,8-9,11,13,15H,7,24H2,1H3,(H,25,26,29)/t13-,15+/m0/s1
InChIKeyYFZHOGUJFUDAPU-DZGCQCFKSA-N
XLogP2.56
TPSA118.73 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500398.43
LogP ≤ 52.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide?
The IUPAC name of cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide (CID 135342332) is cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide.
What is the SMILES notation for cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide?
The canonical SMILES for cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide is Cn1c(=O)n(-c2cc(N)c3cnc(NC(=O)[C@@H]4C[C@H]4C#N)cc3c2)c2ccccc21.
What is the InChIKey of cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide?
The InChIKey is YFZHOGUJFUDAPU-DZGCQCFKSA-N. The full InChI is InChI=1S/C22H18N6O2/c1-27-18-4-2-3-5-19(18)28(22(27)30)14-6-12-8-20(25-11-16(12)17(24)9-14)26-21(29)15-7-13(15)10-23/h2-6,8-9,11,13,15H,7,24H2,1H3,(H,25,26,29)/t13-,15+/m0/s1.
What are the key properties of cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide?
cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide has a molecular weight of 398.43 g/mol, XLogP of 2.56, 3 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for cis-(1R,2R)-N-[8-amino-6-(3-methyl-2-oxobenzimidazol-1-yl)isoquinolin-3-yl]-2-cyanocyclopropane-1-carboxamide is sourced from PubChem (CID 135342332), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).